What if the next blockbuster drug isn’t a molecule – but a frequency?
Electrome is leveraging AI to translate decades of bioelectric science into first-in-class treatments and novel combination therapies across high-burden disease areas.
Welcome to the Electrome
The Electrome Platform enables pioneering research and commercialization of therapies that harness the power of bioelectricity to transform both standalone and combination therapies.


360 Approach to Bioelectric Research, Development, and Commercialization
The Electrome Platform is designed to enable drug developers to rapidly identify, validate, and deliver targeted bioelectric signals that modulate ion channels and cellular voltage with extraordinary precision.
Scalable Bioelectric Therapeutics Platform
We are building the world’s first scalable platform for precision bioelectric therapies—non-invasive, programmable, and clinically validated to treat pain, inflammation, infection, and cancer.



Wound Healing
Enhances tissue regeneration and healing outcomes across surgical and chronic wounds.

Infectious Disease
Targets antibiotic-resistant bacteria through non-chemical, frequency-based disruption.

Oncology
Precise, non-invasive signal-based modulation of tumor microenvironments and growth cycles.

Why start with Our Solutions?

Accelerate time to value

Future-proof your R&D informatics

Ensure successful R&D outcomes

very tested
Elecrome is powering a new era of Precision Medicine
The Electrome Platform enables pharmaceutical companies to identify programmable bioelectric signals that work in synergy with drugs to minimize side effects, unlock novel mechanisms, and enhance efficacy.

Minimize Side Effects
By stabilizing aberrant cellular voltage, bioelectric signals can reduce off-target effects, enabling lower doses and improved safety profiles.

Enable Novel Combinations
Electrome creates a new therapeutic class where waveform-based modulation works in tandem with pharmaceuticals—amplifying mechanisms of action and uncovering new therapeutic windows.

Enhance Drug Efficacy
Bioelectric modulation improves cellular uptake, prolongs therapeutic action, and primes biological systems for a stronger, more targeted response.

Scalable Bioelectric Therapeutics Platform
The world’s first scalable platform for precision bioelectric therapies, non-invasive, programmable, and clinically validated to treat pain, inflammation, infection, cancer, and beyond…

Pain & Inflammation
Alleviate pain, calm inflammation, and accelerate recovery with precision bioelectric signals—offering non-invasive relief while helping reduce reliance on opioids.

Wound Healing
Accelerate tissue regeneration and reduce scarring with bioelectric signals that promote angiogenesis, activate fibroblasts, and modulate immune response throughout the healing process.

Infectious Disease
Combat antibiotic-resistant pathogens with precision electromagnetic signals that disrupt membranes, impair biofilms, and support immune defense.

Oncology
Target cancer cells with precision using electromagnetic signals proven to disrupt tumor growth, modulate immune response, and complement traditional oncology therapies.

Neurology
Activates neuroplastic repair pathways to support recovery from stroke, injury, neurodegenerative decline, and optimizing brain health.

Longevity
Stimulates cellular pathways tied to aging, improving tissue regeneration, metabolic balance, and resilience over time.
The Electrome Platform

Why Work with Us?
We are creating an entirely new category in medicine—bioelectric therapeutics—grounded in decades of peer-reviewed science. Our first product is FDA-ready and set to generate revenue in year one.

Robust Scientific Evidence
Grounded in decades of peer-reviewed research and real-world clinical outcomes.

Platform Business Model
Scalable across multiple indications and device form factors—from consumer to clinical.

Accelerated Time to Market
Stepwise FDA clearance strategy built on 510(k) and De Novo pathways with predicate devices in place.

Regulatory & IP Leadership
Veteran team with clinical, science, FDA, CMS, and IP experience and track record of commercial success.
Led by Proven Innovators
From academic medicine to federal health and commercialization, our team draws on decades of experience across institutions shaping modern healthcare.







